Cannabinoids and glaucoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15090428.
- Also identified by PMC identifier 1772142.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.
Medical subject headings
- Cannabinoids
- Glaucoma
- Phytotherapy